Irina Sánchez-Diener

In vivo validation of peptidoglycan recycling as target to disable AmpC-mediated resistance and reduce virulence enhancing the cell-wall-targeting immunity.

A. Oliver, C. Juan, Gabriel Torrens, 2019, The Journal of infectious diseases.

Pathogenic characteristics of Pseudomonas aeruginosa bacteraemia isolates in a high-endemicity setting for ST175 and ST235 high-risk clones

A. Oliver, E. Viedma, F. Chaves, 2019, European Journal of Clinical Microbiology & Infectious Diseases.

Interplay among Resistance Profiles, High-Risk Clones, and Virulence in the Caenorhabditis elegansPseudomonas aeruginosa Infection Model

A. Oliver, X. Mulet, R. del Campo, 2017, Antimicrobial Agents and Chemotherapy.

Weighting the impact of virulence on the outcome of Pseudomonas aeruginosa bloodstream infections.

A. Oliver, L. Martínez-Martínez, E. Calbo, 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Association between Pseudomonas aeruginosa O-antigen serotypes, resistance profiles and high-risk clones: results from a Spanish nationwide survey.

A. Oliver, G. Bou, L. Martínez-Martínez, 2019, The Journal of antimicrobial chemotherapy.

Activity of Imipenem-Relebactam against a Large Collection of Pseudomonas aeruginosa Clinical Isolates and Isogenic β-Lactam-Resistant Mutants

A. Oliver, G. Bou, L. Martínez-Martínez, 2019, Antimicrobial Agents and Chemotherapy.

In vitro dynamics and mechanisms of resistance development to imipenem and imipenem/relebactam in Pseudomonas aeruginosa.

A. Oliver, C. Juan, B. Moyá, 2020, The Journal of antimicrobial chemotherapy.

Synergistic activity of fosfomycin, &bgr;-lactams and peptidoglycan recycling inhibition against Pseudomonas aeruginosa

A. Oliver, J. Blázquez, Mitchell Hattie, 2017, The Journal of antimicrobial chemotherapy.

Role of Pseudomonas aeruginosa Low-Molecular-Mass Penicillin-Binding Proteins in AmpC Expression, β-Lactam Resistance, and Peptidoglycan Structure

A. Oliver, J. Ayala, B. Moyá, 2015, Antimicrobial Agents and Chemotherapy.

Molecular Analysis of the Contribution of Alkaline Protease A and Elastase B to the Virulence of Pseudomonas aeruginosa Bloodstream Infections

A. Oliver, A. Doménech-Sánchez, L. Zamorano, 2022, Frontiers in Cellular and Infection Microbiology.

Spanish nationwide survey on Pseudomonas aeruginosa antimicrobial resistance mechanisms and epidemiology.

A. Oliver, G. Bou, L. Martínez-Martínez, 2019, The Journal of antimicrobial chemotherapy.

In vitro evolution of cefepime/zidebactam (WCK 5222) resistance in Pseudomonas aeruginosa: dynamics, mechanisms, fitness trade-off and impact on in vivo efficacy.

A. Oliver, S. Palwe, B. Moyá, 2021, The Journal of antimicrobial chemotherapy.

Deciphering &bgr;-lactamase-independent &bgr;-lactam resistance evolution trajectories in Pseudomonas aeruginosa

A. Oliver, G. Cabot, L. Zamorano, 2018, The Journal of antimicrobial chemotherapy.